184 related articles for article (PubMed ID: 2879902)
21. Human N-demethylation of (S)-mephenytoin by cytochrome P450s 2C9 and 2B6.
Ko JW; Desta Z; Flockhart DA
Drug Metab Dispos; 1998 Aug; 26(8):775-8. PubMed ID: 9698292
[TBL] [Abstract][Full Text] [Related]
22. In vitro metabolism of the biguanide antimalarials in human liver microsomes: evidence for a role of the mephenytoin hydroxylase (P450 MP) enzyme.
Helsby NA; Ward SA; Howells RE; Breckenridge AM
Br J Clin Pharmacol; 1990 Aug; 30(2):287-91. PubMed ID: 2206791
[TBL] [Abstract][Full Text] [Related]
23. Human CYP2C-mediated stereoselective phenytoin hydroxylation in Japanese: difference in chiral preference of CYP2C9 and CYP2C19.
Yasumori T; Chen LS; Li QH; Ueda M; Tsuzuki T; Goldstein JA; Kato R; Yamazoe Y
Biochem Pharmacol; 1999 Jun; 57(11):1297-303. PubMed ID: 10230773
[TBL] [Abstract][Full Text] [Related]
24. Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms.
Andersson T; Miners JO; Veronese ME; Birkett DJ
Br J Clin Pharmacol; 1994 Aug; 38(2):131-7. PubMed ID: 7981013
[TBL] [Abstract][Full Text] [Related]
25. Evidence that CYP2C19 is the major (S)-mephenytoin 4'-hydroxylase in humans.
Goldstein JA; Faletto MB; Romkes-Sparks M; Sullivan T; Kitareewan S; Raucy JL; Lasker JM; Ghanayem BI
Biochemistry; 1994 Feb; 33(7):1743-52. PubMed ID: 8110777
[TBL] [Abstract][Full Text] [Related]
26. A convenient assay for mephenytoin 4-hydroxylase activity of human liver microsomal cytochrome P-450.
Shimada T; Shea JP; Guengerich FP
Anal Biochem; 1985 May; 147(1):174-9. PubMed ID: 4025815
[TBL] [Abstract][Full Text] [Related]
27. Polymorphism in hydroxylation of mephenytoin and hexobarbital stereoisomers in relation to hepatic P-450 human-2.
Yasumori T; Murayama N; Yamazoe Y; Kato R
Clin Pharmacol Ther; 1990 Mar; 47(3):313-22. PubMed ID: 2311333
[TBL] [Abstract][Full Text] [Related]
28. Characterization of monkey cytochrome P450, P450 CMLd, responsible for S-mephenytoin 4-hydroxylation in hepatic microsomes of cynomolgus monkeys.
Ohmori S; Chiba K; Nakasa H; Horie T; Kitada M
Arch Biochem Biophys; 1994 Jun; 311(2):395-401. PubMed ID: 8203903
[TBL] [Abstract][Full Text] [Related]
29. Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4'-hydroxylase cytochrome P-450 enzymes.
Srivastava PK; Yun CH; Beaune PH; Ged C; Guengerich FP
Mol Pharmacol; 1991 Jul; 40(1):69-79. PubMed ID: 1857342
[TBL] [Abstract][Full Text] [Related]
30. In vitro inhibition studies of two isozymes of human liver cytochrome P-450. Mephenytoin p-hydroxylase and sparteine monooxygenase.
Inaba T; Jurima M; Mahon WA; Kalow W
Drug Metab Dispos; 1985; 13(4):443-8. PubMed ID: 2863108
[TBL] [Abstract][Full Text] [Related]
31. Development and preliminary application of a simple assay of S-mephenytoin 4-hydroxylase activity in human liver microsomes.
Chiba K; Manabe K; Kobayashi K; Takayama Y; Tani M; Ishizaki T
Eur J Clin Pharmacol; 1993; 44(6):559-62. PubMed ID: 8405013
[TBL] [Abstract][Full Text] [Related]
32. CYP2C19-mediated (S)-mephenytoin 4'-hydroxylation assayed by high-performance liquid chromatography with radiometric detection.
Crespi CL; Chang TK; Waxman DJ
Methods Mol Biol; 2006; 320():115-9. PubMed ID: 16719381
[TBL] [Abstract][Full Text] [Related]
33. P-hydroxylation of phenobarbital: relationship to (S)-mephenytoin hydroxylation (CYP2C19) polymorphism.
Hadama A; Ieiri I; Morita T; Kimura M; Urae A; Irie S; Kaneda T; Mamiya K; Tashiro N; Higuchi S; Otsubo K
Ther Drug Monit; 2001 Apr; 23(2):115-8. PubMed ID: 11294510
[TBL] [Abstract][Full Text] [Related]
34. Carbamazepine and oxcarbazepine decrease phenytoin metabolism through inhibition of CYP2C19.
Lakehal F; Wurden CJ; Kalhorn TF; Levy RH
Epilepsy Res; 2002 Dec; 52(2):79-83. PubMed ID: 12458024
[TBL] [Abstract][Full Text] [Related]
35. Selective effect of liver disease on the activities of specific metabolizing enzymes: investigation of cytochromes P450 2C19 and 2D6.
Adedoyin A; Arns PA; Richards WO; Wilkinson GR; Branch RA
Clin Pharmacol Ther; 1998 Jul; 64(1):8-17. PubMed ID: 9695714
[TBL] [Abstract][Full Text] [Related]
36. Mephenytoin metabolism in vitro by human liver.
Jurima M; Inaba T; Kalow W
Drug Metab Dispos; 1985; 13(2):151-5. PubMed ID: 2859161
[TBL] [Abstract][Full Text] [Related]
37. Genetic tests which identify the principal defects in CYP2C19 responsible for the polymorphism in mephenytoin metabolism.
Goldstein JA; Blaisdell J
Methods Enzymol; 1996; 272():210-8. PubMed ID: 8791779
[No Abstract] [Full Text] [Related]
38. Expression of a human P-450IIC gene in yeast cells using galactose-inducible expression system.
Yasumori T; Murayama N; Yamazoe Y; Abe A; Nogi Y; Fukasawa T; Kato R
Mol Pharmacol; 1989 Apr; 35(4):443-9. PubMed ID: 2649791
[TBL] [Abstract][Full Text] [Related]
39. Genetic polymorphism of mephenytoin metabolism.
Inaba T
Prog Clin Biol Res; 1986; 214():139-56. PubMed ID: 3523505
[No Abstract] [Full Text] [Related]
40. Mephenytoin-type polymorphism of drug oxidation: purification and characterization of a human liver cytochrome P-450 isozyme catalyzing microsomal mephenytoin hydroxylation.
Gut J; Meier UT; Catin T; Meyer UA
Biochim Biophys Acta; 1986 Dec; 884(3):435-47. PubMed ID: 3096378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
